ãµã€ãºãéžæããŠãã ãã
衚瀺ã倿Žãã
ãã®ååã«ã€ããŠ
å®éšåŒïŒãã«è¡šèšæ³ïŒ:
C18H19ClN4 · 3HCl
CASçªå·:
ååé:
436.21
MDL number:
UNSPSC Code:
12352200
NACRES:
NA.77
eCl@ss:
32160701
ãã°ã€ã³ïŒäŸ¡æ Œã確èªãã
ãã¯ãã«ã«ãµãŒãã¹
ãå°ãã®ããšãããã°ãçµéšè±å¯ãªãã¯ãã«ã«ãµãŒãã¹ããŒã ãã客æ§ããµããŒãããŸãã
ãæäŒãããŸãassay
≥99% (HPLC)
Quality Segment
form
solid
potency
0.4 nM Ki
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, protect from light
color
off-white
solubility
water: soluble
storage temp.
2-8°C
SMILES string
Clc1ccc(cc1)N2CCN(CC2)Cc3c4c([nH]c3)nccc4
InChI
1S/C18H19ClN4/c19-15-3-5-16(6-4-15)23-10-8-22(9-11-23)13-14-12-21-18-17(14)2-1-7-20-18/h1-7,12H,8-11,13H2,(H,20,21)
InChI key
OGJGQVFWEPNYSB-UHFFFAOYSA-N
General description
Selective D4 receptor antagonist with excellent brain penetration. Displays an affinity (Ki) of 0.4 nM for human D4 receptors with >1000-fold binding selectivity over D2 and D3 receptors. Does not block agonist-induced activation of GIRK currents. It is used frequently in retinal and CNS studies of D4 modulation.
Biochem/physiol Actions
Primary Target
Dâ
Dâ
Reversible: yes
Preparation Note
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Other Notes
Li, H. et al., 2013. J. Neurosci.33, 3135.
Pillai, G. et al. 1998. Neuropharmacol.337, 983.
Kulagowski, J. et al. 1996. J. Med. Chem.39, 1941.
Pillai, G. et al. 1998. Neuropharmacol.337, 983.
Kulagowski, J. et al. 1996. J. Med. Chem.39, 1941.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
ä¿ç®¡åé¡
11 - Combustible Solids
WGK
WGK 3
åŒç«ç¹ (F)
Not applicable
åŒç«ç¹ïŒÂ°CïŒ
Not applicable
ææ°ããŒãžã§ã³ã®ãããããéžæããŠãã ããïŒ
以åãã®è£œåãè³Œå ¥ããã ããããšãããå Žå
ææžã©ã€ãã©ãªã§ãæè¿è³Œå ¥ãã補åã®ææžãæ€çŽ¢ã§ããŸãã